A detailed history of Davenport & CO LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Davenport & CO LLC holds 219,709 shares of VRTX stock, worth $89.7 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
219,709
Previous 221,525 0.82%
Holding current value
$89.7 Million
Previous $104 Million 1.59%
% of portfolio
0.61%
Previous 0.65%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$460.0 - $505.78 $835,360 - $918,496
-1,816 Reduced 0.82%
219,709 $102 Million
Q2 2024

Aug 06, 2024

BUY
$392.81 - $485.53 $1.07 Million - $1.33 Million
2,734 Added 1.25%
221,525 $104 Million
Q1 2024

May 03, 2024

SELL
$407.69 - $446.08 $182,237 - $199,397
-447 Reduced 0.2%
218,791 $91.5 Million
Q4 2023

Jan 23, 2024

BUY
$343.0 - $410.68 $35.6 Million - $42.6 Million
103,769 Added 89.87%
219,238 $89.2 Million
Q3 2023

Oct 17, 2023

SELL
$338.18 - $362.46 $149,475 - $160,207
-442 Reduced 0.38%
115,469 $40.2 Million
Q2 2023

Jul 20, 2023

BUY
$314.42 - $351.91 $31.9 Million - $35.7 Million
101,567 Added 708.08%
115,911 $40.8 Million
Q1 2023

Apr 27, 2023

SELL
$283.23 - $323.1 $111,592 - $127,301
-394 Reduced 2.67%
14,344 $4.52 Million
Q4 2022

Jan 20, 2023

BUY
$285.76 - $321.48 $44,864 - $50,472
157 Added 1.08%
14,738 $0
Q3 2022

Oct 11, 2022

SELL
$273.83 - $305.53 $1.72 Million - $1.92 Million
-6,284 Reduced 30.12%
14,581 $4.22 Million
Q2 2022

Jul 18, 2022

SELL
$234.96 - $292.55 $330,118 - $411,032
-1,405 Reduced 6.31%
20,865 $5.88 Million
Q1 2022

May 02, 2022

BUY
$221.42 - $260.97 $343,865 - $405,286
1,553 Added 7.5%
22,270 $5.81 Million
Q4 2021

Feb 10, 2022

BUY
$177.01 - $223.45 $410,309 - $517,957
2,318 Added 12.6%
20,717 $4.55 Million
Q3 2021

Oct 14, 2021

BUY
$181.39 - $202.99 $230,728 - $258,203
1,272 Added 7.43%
18,399 $3.34 Million
Q2 2021

Jul 28, 2021

SELL
$187.49 - $221.1 $23.3 Million - $27.5 Million
-124,507 Reduced 87.91%
17,127 $3.45 Million
Q1 2021

Apr 28, 2021

BUY
$207.02 - $241.31 $1.78 Million - $2.07 Million
8,598 Added 6.46%
141,634 $30.4 Million
Q4 2020

Jan 13, 2021

BUY
$207.01 - $276.09 $27.1 Million - $36.2 Million
131,123 Added 6854.31%
133,036 $31.4 Million
Q3 2020

Oct 15, 2020

BUY
$255.65 - $303.1 $489,058 - $579,830
1,913 New
1,913 $521,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.